Lipoprotein Lipase Antikörper (Center)
Kurzübersicht für Lipoprotein Lipase Antikörper (Center) (ABIN2798466)
Target
Alle Lipoprotein Lipase (LPL) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 300-327, Center
-
Verwendungszweck
- Rabbit Anti-Human LPL (Center) Antibody
-
Immunogen
- This LPL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 300-327 amino acids from the Central region of human LPL.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
-
Western Blot, Immunohistochemistry, Flow Cytometry
Recommended Dilutions
WB: 1:1000, IHC: 1:10-50, FC: 1:10-50LPL Antibody (Center) .FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2-8°C (short-term), -20°C (long-term)
-
-
- Lipoprotein Lipase (LPL)
-
Andere Bezeichnung
- LPL
-
Hintergrund
-
Target Description: LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq].
Gene Symbol: LPL
-
Molekulargewicht
- 53162 Da
-
Gen-ID
- 4023
-
UniProt
- P06858
-
Pathways
- Lipid Metabolism
Target
-